New Treatment for Pediatric Patients with Type 2 Diabetes
Pediatric patients with type 2 diabetes have a new treatment option this year. The U.S. Food and Drug Administration (FDA) approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients since metformin was […]
